Greenstone Biosciences Revenue
Biotechnology Research • 
Palo Alto, California, United States • 11-20 Employees
Greenstone Biosciences revenue & valuation
| Annual revenue | $1,625,545 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,300,000 |
| Total funding | $2,800,000 |
Key Contacts at Greenstone Biosciences
Mukhtar Ahmed Ph. D.
Director, Project & Portfolio Strategy
Honit Piplani
Director, Translational And Clinical Science
Paul Pang
Director, Head Of Research & Development
Todd Herron
Director Hipsc Biobank
Christopher Yan
Associate Director, Commercial Strategy & Operations
Jade Chao
Co-Founder
Paul Pang
Director
Company overview
| Headquarters | 3160 Porter Dr, Palo Alto, California 94304, US |
| Phone number | +16507147060 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Drug Discovery, Genomics, AI, Computational Biology, Ipsc |
| Founded | 2022 |
| Employees | 11-20 |
| Socials |
Greenstone Biosciences Email Formats
Greenstone Biosciences uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@greenstonebio.com), used 86.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@greenstonebio.com | 86.7% |
{first initial}{second initial} | jo@greenstonebio.com | 6.7% |
{first initial}{last name} | jdoe@greenstonebio.com | 6.7% |
About Greenstone Biosciences
Discover the limitless potential of human induced pluripotent stem cells (iPSCs) for groundbreaking research at Greenstone, a leading Bay Area biotech company. We combine cutting-edge technology with AI, computational biology, and pharmacogenomics to accelerate drug discovery and development, transforming the future of therapeutics. Our vision is to transform drug discovery from a slow, sequential, and high-failure process into a rapid, integrated, and novel computational platform. By harnessing the power of iPSCs and our advanced technologies, we revolutionize the traditional drug discovery paradigm, paving the way for a faster, more efficient approach. With our curated and diverse collection of iPSCs, sourced from both healthy individuals and those affected by various diseases, we offer a comprehensive platform for disease modeling, uncovering novel mechanisms, and advancing drug discovery. Our high-quality iPSCs provide researchers with patient-specific and disease-specific cells, enabling the development of personalized treatment strategies. At Greenstone, collaboration and innovation are at the core of our values. We proudly offer our iPSCs to academic investigators free of cost, fostering an environment of shared knowledge and progress. Together, we can unlock new insights, accelerate drug discovery, and shape the future of personalized medicine. Join us on the frontier of biomedical research and tap into the immense potential of iPSCs. Together, let's transform drug discovery into a rapid, integrated, and computational platform that propels us towards groundbreaking therapeutics. #Biotech #iPSCs #DrugDiscovery #BiomedicalResearch #PersonalizedMedicine #Innovation
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Greenstone Biosciences has 6 employees across 3 departments.
Departments
Number of employees
Greenstone Biosciences Tech Stack
Discover the technologies and tools that power Greenstone Biosciences's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
WordPress themes
WordPress plugins
Analytics
JavaScript libraries
JavaScript libraries
Maps
Page builders
JavaScript libraries
Font scripts
JavaScript libraries
Spain
France
Sri Lanka
Belgium
Frequently asked questions
4.8
40,000 users
